In silico analysis and comprehensive review of circular-RNA regulatory roles in breast diseases; a step-toward non-coding RNA precision
dc.Affiliation | October University for modern sciences and Arts MSA | |
dc.contributor.author | Nadia M. Hamdy | |
dc.contributor.author | Mona G. El-Sisi | |
dc.contributor.author | Sherine M. Ibrahim | |
dc.contributor.author | Heba ElNokoudy | |
dc.contributor.author | Ahmad A. Hady | |
dc.contributor.author | Gamal Eldein Fathy Abd-ellatef | |
dc.contributor.author | Al-Aliaa M. Sallam | |
dc.contributor.author | Bassant Mohamed Barakat | |
dc.date.accessioned | 2024-11-12T11:59:21Z | |
dc.date.available | 2024-11-12T11:59:21Z | |
dc.date.issued | 2024-10-19 | |
dc.description.abstract | In the current comprehensive review, we first highlighted circRNAs, which are key ncRNAs. Next, we discussed the relationships among circRNAs and breast cancer subtypes via in silico databases analysis and extensive literature search. CircRNAs, that sponge miRNA axes or act as silencers of oncogenic mRNAs, have been extensively addressed in the context of this review. During BC pathogenesis, the circRNA/microRNA/messenger RNA (mRNA) axis plays a major role in disease growth, progression, and survival/resistance and could be targeted for improved treatment options. This review also aimed to address oncogenic and tumor suppressor mRNAs, which are regulated by various circRNAs in BC. Moreover, we mentioned the relation of different circRNAs with cancer hallmarks, patient survival together with drug resistance. Additionally, we discussed circRNAs as vaccines and biomarkers in BC. Finally, we studied exosomal circRNAs as a hot interesting area in the research. | |
dc.description.uri | https://www.scimagojr.com/journalsearch.php?q=16987&tip=sid&clean=0#google_vignette | |
dc.identifier.citation | Hamdy, N. M., El-Sisi, M. G., Ibrahim, S. M., ElNokoudy, H., Hady, A. A., Abd-Ellatef, G. E. F., Sallam, A. M., & Barakat, B. M. (2024). In silico Analysis and Comprehensive Review of Circular-RNA Regulatory Roles in Breast Diseases; a Step-Toward non-coding RNA Precision. Pathology - Research and Practice, 263, 155651. https://doi.org/10.1016/j.prp.2024.155651 | |
dc.identifier.doi | https://doi.org/10.1016/j.prp.2024.155651 | |
dc.identifier.other | https://doi.org/10.1016/j.prp.2024.155651 | |
dc.identifier.uri | https://repository.msa.edu.eg/handle/123456789/6225 | |
dc.language.iso | en | |
dc.publisher | Elsevier GmbH | |
dc.relation.ispartofseries | Pathology - Research and Practice ; 263 (2024) 155651 | |
dc.subject | Nc-epigeneticsCircular RNAs (circRNA)Breast cancer (BC)TNBCExosomesin silicoPrecision medicine (PM) | |
dc.subject | Circular RNAs (circRNA) | |
dc.subject | Breast cancer (BC) | |
dc.subject | TNBC | |
dc.subject | Exosomes | |
dc.subject | in silico | |
dc.subject | Precision medicine (PM) | |
dc.title | In silico analysis and comprehensive review of circular-RNA regulatory roles in breast diseases; a step-toward non-coding RNA precision | |
dc.type | Article |